Alfred “Freddie” Bowie, Jr., Ph.D.
Vice President, Corporate and Business Development
Alfred “Freddie” Bowie was appointed Vice President of Corporate and Business Development of Veractye in April 2019. In this role, Dr. Bowie will lead the company’s strategic planning process and is responsible for managing biopharmaceutical collaborations; identifying, evaluating and executing technology and business partnerships; and managing licensing and acquisitions.
Prior to joining Veracyte, Dr. Bowie served as Senior Director of Corporate Development and Strategy at Foundation Medicine, where from June 2016 through April 2019 he led strategic planning, corporate development and competitive intelligence, helping drive corporate growth and business collaborations. Dr. Bowie also was Director of Corporate Development at Tecan Group from May 2014 through May 2016, and before that, he was a business development manager at Danaher Corporation from March 2012 through May 2014.
Dr. Bowie holds a Bachelor of Science degree in Chemistry from Davidson College and a Ph.D. in Organic Chemistry and Chemical Biology from University of California, Berkeley. He also completed an NIH fellowship at the Institute of Chemistry and Chemical Biology at HMS.